** Brokerage Jefferies trim price target on Australia's Monash IVF MVF.AX to A$1.25 per share from A$1.45 per share
** Monash on Tuesday, downgraded its FY25 underlying NPAT forecast to about A$27.5 million ($17.69 million), from its previous forecast of A$30.0 million to A$31.0 million
** Believe this is in part due to the somewhat discretionary nature of IVF as well as MVF’s exposure to Victoria, a state that is facing economic challenges - Jefferies
** Six of seven analysts rate the stock "buy" or higher, one "hold"; their median PT is A$1.17, according to data compiled by LSEG
** Stock has fallen 39.4% this year, as of last close
($1 = 1.5545 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。